A. EROĞLU Et Al. , "The efficacy of tissue factor 603A G and 5466A G polimorphisms at the development of venous thromboembolism in cancer patients," EXPERIMENTAL ONCOLOGY , vol.38, no.3, pp.187-190, 2016
EROĞLU, A. Et Al. 2016. The efficacy of tissue factor 603A G and 5466A G polimorphisms at the development of venous thromboembolism in cancer patients. EXPERIMENTAL ONCOLOGY , vol.38, no.3 , 187-190.
EROĞLU, A., GÜLEÇ CEYLAN, G., öztürk, e., YALÇIN, A., YALÇIN, B., & KARASOY, D., (2016). The efficacy of tissue factor 603A G and 5466A G polimorphisms at the development of venous thromboembolism in cancer patients. EXPERIMENTAL ONCOLOGY , vol.38, no.3, 187-190.
EROĞLU, AYDAN Et Al. "The efficacy of tissue factor 603A G and 5466A G polimorphisms at the development of venous thromboembolism in cancer patients," EXPERIMENTAL ONCOLOGY , vol.38, no.3, 187-190, 2016
EROĞLU, AYDAN Et Al. "The efficacy of tissue factor 603A G and 5466A G polimorphisms at the development of venous thromboembolism in cancer patients." EXPERIMENTAL ONCOLOGY , vol.38, no.3, pp.187-190, 2016
EROĞLU, A. Et Al. (2016) . "The efficacy of tissue factor 603A G and 5466A G polimorphisms at the development of venous thromboembolism in cancer patients." EXPERIMENTAL ONCOLOGY , vol.38, no.3, pp.187-190.
@article{article, author={AYDAN EROĞLU Et Al. }, title={The efficacy of tissue factor 603A G and 5466A G polimorphisms at the development of venous thromboembolism in cancer patients}, journal={EXPERIMENTAL ONCOLOGY}, year=2016, pages={187-190} }